A Study of the Efficacy and Safety of Alteplase in Participants With Mild Stroke

NCT02072226 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

313

Enrollment

INDUSTRY

Sponsor class

Stopped The study was terminated due to slow enrollment.

Conditions

Stroke

Interventions

DRUG: Alteplase
DRUG: Alteplase Placebo
DRUG: Aspirin
DRUG: Aspirin Placebo

Sponsor

Genentech, Inc.